Trend

Last Previous Currency Date Chng
100.11 99.60 USD 26/06/12 +0.51

Terms

Isin LU0195948822
Contract Type Sicav
Currency USD
Class I
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech
Start Date 04/08/31
Advisor Name Evan McCulloch; Vincent Xiang
Fund Asset Under Management N.Av.

Performance

Cumulatives
1 month -1.86
Ytd +6.37
1 year +61.82
3 years +73.21
5 years +54.91
Yearly
05/31/2025 +34.77
05/31/2024 +10.10
05/31/2023 +14.18
05/31/2022 -6.31
05/31/2021 -9.70
Rating
N.Av.
Score
N.Av.

Company

Franklin Templeton Int. Serv.
8A, rue Albert Borschette L-1246 - LUXEMBOURG
Tel. N.Av.

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 0.7
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial 5000000,0000 USD
Integrative 1000,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 5000000,0000

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 0.7
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day +0.25
1 week +3.31
1 month -1.86
3 months +4.98
6 months +5.79
From the beginning of the year +6.37
1 year +61.82
2 years +40.15
3 years +73.21
4 years +110.51
5 years +54.91
Yearly
05/31/2025 +34.77
05/31/2024 +10.10
05/31/2023 +14.18
05/31/2022 -6.31
05/31/2021 -9.70


Rating
N.Av.
Score
N.Av.

Efficiency Indicators

Sharpe 1 year 2.2049
Benchmark 1 year N.Av.
Sharpe 3 years 0.8554
Benchmark 3 years N.Av.
Sharpe 5 years 0.4426
Benchmark 5 years N.Av.
Sortino 1 year 11.4349
Benchmark 1 year N.Av.
Sortino 3 years 1.8585
Benchmark 3 years N.Av.
Sortino 5 years 0.8195
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +21.88
3 years +20.78
5 years +19.53
Negative Volatility
1 year +4.22
3 years +9.58
5 years +10.49

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/05/29

Relative

Sharpe 0.8554
Sortino 1.8585
Bull Market +10.82
Bear Market -4.02
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 18,162 3 years 16,061 5 years 14,393
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,162
4,277
  
+71.01
3 years 16,061
4,945
  
+82.62
5 years 14,393
8,980
  
+71.06
Performance
4,277 +71.01 4,945 +82.62 8,980 +71.06
Total Volatility
1 year 18,162
20,784
  
+21.88
3 years 16,061
16,922
  
+20.78
5 years 14,393
13,833
  
+19.53
Total Volatility
20,784 +21.88 16,922 +20.78 13,833 +19.53
Negative Volatility
1 year 18,162
17,705
  
+4.22
3 years 16,061
16,896
  
+9.58
5 years 14,393
13,918
  
+10.49
Negative Volatility
17,705 +4.22 16,896 +9.58 13,918 +10.49
Sharpe Index
1 year 18,162
16,553
  
+2.20
3 years 16,061
12,374
  
+0.86
5 years 14,393
11,190
  
+0.44
Sharpe Index
16,553 +2.20 12,374 +0.86 11,190 +0.44
Sortino Index
1 year 18,162
12,790
  
+11.43
3 years 16,061
11,899
  
+1.86
5 years 14,393
11,207
  
+0.82
Sortino Index
12,790 +11.43 11,899 +1.86 11,190 +0.82

By Category

  1 year 18,162 3 years 16,061 5 years 14,393
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,162
44
  
+71.01
3 years 16,061
71
  
+82.62
5 years 14,393
61
  
+71.06
Performance
44 +71.01 71 +82.62 61 +71.06
Total Volatility
1 year 18,162
72
  
+21.88
3 years 16,061
73
  
+20.78
5 years 14,393
69
  
+19.53
Total Volatility
72 +21.88 73 +20.78 69 +19.53
Negative Volatility
1 year 18,162
70
  
+4.22
3 years 16,061
71
  
+9.58
5 years 14,393
67
  
+10.49
Negative Volatility
70 +4.22 71 +9.58 67 +10.49
Sharpe Index
1 year 18,162
58
  
+2.20
3 years 16,061
71
  
+0.86
5 years 14,393
61
  
+0.44
Sharpe Index
58 +2.20 71 +0.86 61 +0.44
Sortino Index
1 year 18,162
56
  
+11.43
3 years 16,061
71
  
+1.86
5 years 14,393
59
  
+0.82
Sortino Index
56 +11.43 71 +1.86 59 +0.82

Foreign Funds - Franklin Biotechnology Discovery I $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.